文献速递肝病消化道出血消化内镜

门静脉高压性胃病与MELD-Na评分预测TIPSS术后复发性消化道出血:ALTA协作组研究

Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.
PubMed 文献 · Aliment Pharmacol Ther · 2024-11-05

该研究基于ALTA多中心数据库回顾性纳入476例因食管胃静脉曲张出血二级预防接受TIPSS的成人患者,16%(n=77)在1年内发生消化道再出血。校正TIPSS修正后,多变量分析显示MELD-Na评分及TIPSS术前内镜下的门静脉高压性胃病与再出血独立相关。

要点

  • TIPSS术后1年内消化道再出血率为16%(77/476)。
  • 再出血患者MELD-Na更高、术前存在门静脉高压性胃病。
  • 校正TIPSS修正后,高MELD-Na与门静脉高压性胃病为独立预测因素。

核心结论

  • 除TIPSS相关因素外,高MELD-Na和TIPSS术前内镜下的门静脉高压性胃病是TIPSS术后1年内再出血的独立预测因素。
  • 这些变量或可用于识别TIPSS术后可能需要额外监测的高危患者。

研究设计与样本

  • 利用Advancing Liver Therapeutic Approaches(ALTA)多中心数据库进行的回顾性分析,纳入因食管胃静脉曲张出血二级预防接受TIPSS且1年内发生消化道再出血的成人患者。
  • 共识别476例患者,平均年龄57岁,男性占62%,白人占65%,平均MELD-Na为16。
  • 采用多变量logistic回归模型识别与再出血相关的临床/操作特征。

主要发现

  • 16%(n=77)发生再出血事件;这些患者更可能为男性(p=0.016)、血清肌酐更高(p=0.005)、MELD-Na更高(p=0.0002)、TIPSS术前上消化道内镜存在门静脉高压性胃病(p=0.000)且TIPSS修正发生率更高(p=0.000)。
  • 再出血与未再出血患者在TIPSS内支架类型、同期栓塞治疗及TIPSS术后压力梯度方面无显著差异。
  • 校正TIPSS修正后,多变量分析显示MELD-Na和TIPSS术前内镜下门静脉高压性胃病与再出血独立相关。

临床怎么用

  • 作者认为,高MELD-Na和TIPSS术前内镜下的门静脉高压性胃病或可用于识别TIPSS术后可能需要额外监测的高危患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPSS) is highly effective for treatment of variceal bleeding; however, factors contributing to rebleeding complications remain unclear. AIMS: In this study, we aim to determine risk factors for recurrent portal hypertensive gastrointestinal bleeding following TIPSS. METHODS: Utilising the Advancing Liver Therapeutic Approaches multicentre database, we retrospectively identified adult patients who underwent TIPSS for secondary prophylaxis of variceal bleeding and had a gastrointestinal rebleeding event within 1 year. We developed multivariable logistic regression models to identify clinical/procedural characteristics associated with rebleeding. RESULTS: We identified 476 patients, predominately middle-aged (mean age 57), male (62%) and White (65%), with mean MELD-Na 16. 16% (n = 77) had a rebleeding event; these patients were more likely to be male (p = 0.016), with higher serum creatinine (p = 0.005), MELD-Na (p = 0.0002), portal hypertensive gastropathy on pre-TIPSS upper endoscopy (p = 0.000) and with higher incidence of TIPSS revision (p = 0.000). There were no significant differences in type of TIPSS endoprosthesis, concurrent embolotherapy, and post-TIPSS pressure gradients between those who experienced rebleeding and those who did not. After adjusting for TIPSS revision, multivariable analysis revealed MELD-Na and presence of portal hypertensive gastropathy on pre-TIPSS endoscopy were independently associated with rebleeding. CONCLUSIONS: In this retrospective analysis of a multicentre, nationally representative database, we found that apart from TIPSS-related factors, high MELD-Na and portal hypertensive gastropathy on pre-TIPSS endoscopy were independent predictors of rebleeding within 1 year following TIPSS. These variables may be used to identify high-risk patients who may require additional monitoring following TIPSS.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Hu K, Sedki M, Kwong A, et al. Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Aliment Pharmacol Ther. 2024. PMID: 39501554. doi:10.1111/apt.18362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。